Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOLIN AS
AS
Active
Org 833339702
F. Hennigs Gate 13, 2815 Gjøvik
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2024
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 58K
EBITDA margin
92.4%
Equity ratio
1.2%
Financial strength
Net profit 2024
NOK 24K
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2024
Key figures
Annual report 2024
Revenue
NOK 58K
—
EBITDA
NOK 53K
—
Net profit
NOK 24K
—
Total assets
NOK 3,9M
—
Equity
NOK 49K
—
Employees
—
—
Company information
Legal name
BIOLIN AS
Org number
833339702
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22. april 2024
Share capital
NOK 30 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Forskning og utvikling av 3d-priting samt virksomhet som står i den forbindelse.
Contact
Address
F. Hennigs Gate 13, 2815 Gjøvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Gjøvik
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
NOK thousands
Item
2024
Revenue
58
Staff expenses
−0
EBITDA
53
Depreciation & amort.
−32
EBIT
22
Net financials
8
Profit before tax
30
Tax
5
Net profit
24
Balance sheet
NOK thousands
Item
2024
Total assets
3 946
Equity
49
Long-term debt
3 897
Short-term debt
0
Total debt
3 897
Financial ratios
5-year trend
EBITDA margin
92.4%
This company
15.8%
Market median
+485% vs market
2024
2024
Equity ratio
1.2%
This company
38.2%
Market median
-97% vs market
2024
2024
Return on equity
50.3%
This company
18.4%
Market median
+173% vs market
2024
2024
Net profit margin
42.5%
This company
8.1%
Market median
+425% vs market
2024
2024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
2024
2024
Debt / equity
80.02×
This company
0.62×
Market median
-12806% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
RM
Roy Mathisen
Chief Executive Officer
Chief Executive Officer
2024
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
RH
Randi Hildegard Berg Mathisen
Board of Directors
2024
—
—
KB
Kristian Brekke Djuve
Chairman
2024
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BIOLIN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Roy Mathisen
Chief Executive Officer
0 companies
Randi Hildegard Berg Mathisen
Board of Directors
0 companies
Kristian Brekke Djuve
Chairman
0 companies